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1. Introduction 
The structure of the smooth muscle tissue is quite different from that of other muscle tissue 
subtypes. The primary smooth muscle structural and functional unit – the smooth muscle 
myocyte (Myocytus nonstriatus) has unique structure, arrangement and innervation. The 
spindle shape of the mononucleated smooth muscle cell permits a close contact among cells 
in the splanchnic and vascular walls. Regardless of its location in the body, the 
communication between tightly packed adjacent spindle-shaped mononucleated smooth 
muscle cells occurs via a specific junction, referred to as Macula communicans (nexus, gap 
junction). The space between the different macular connexons is about 2 nm, which allows 
low-molecular compounds to pass from one cell to another. This type of junction is 
analogous to the plasmodesma (pl. plasmodesmata), encountered in cells of plants. The 
basement membrane covering each smooth muscle cell, is absent at gap junction sites.  
The contractility, proper of smooth muscle cells, is influenced by the autonomic nervous 
system, hormones and local metabolites, which alter the contractility in a way that adapts to 
the new functional requirements. Smooth muscle cell contraction could be modulated via 
surface receptors, activating internal second messenger systems. The expression of a variety 
of receptors accounts for the response of smooth muscle cells in different areas to a number 
of hormones [1].  
It is known that for the major part of smooth musculature (except for the iris, vas deferens 
and large blood vessels) one autonomic nerve fibre innervates a group of 15-20 smooth 
muscle cells, as the stimulus to one cell is transmitted via nexus contacts to the other [2] 
assuming a simultaneous contraction of the pack of cells. This pathway of stimulus 
transmission naturally raises the question whether the excitation potential decreases 
towards more distant cells and whether the smooth muscle contraction and relaxation is 
mediated by biologically active substances, released by adjacent cells. In this connection, the 
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proof of [3] that in vitro equine cecal smooth muscle contractions could occur without the 
nervous system participation is important to understand the biology of smooth muscle cells. 
Later, other researchers ([4] added new important data about the involvement of an unique, 
in their opinion, adhesion molecule of mast cells – the cell adhesion molecule-1 (CADM-1), 
which mediates the functional communication between mast cells and nerves, as well as 
between smooth muscle and mast cells. They outlined that in bronchial asthma, mast cells 
infiltrated the smooth muscles of airways and interacted directly with smooth muscle cells, 
presuming a role of mastocytes in the pathogenesis of airway obstruction.  
The interaction between mast cells and vascular smooth muscle cells that are largely 
involved in vascular wall motility is of special interest for the cardiovascular system 
function. The presence of mast cells in blood vessels’ wall and especially in the tunica media 
(the muscle layer), supposes a participation in smooth muscle cell activity modulation via 
release of vasoactive mediators. A similar effect could be hypothesized when mast cells are 
located close to the blood vessels from the microcirculatory bed and to arterioles in 
particular, as it is recognized that arterial blood pressure is largely influenced by the smooth 
muscle tone in the wall of arterioles.  
Besides the classic and more recent data about biologically active substances released by 
mast cells, and implicated in smooth muscle cell activity, this chapter presents concisely 
some original information about the localization of mast cells in muscle layers of blood 
vessels and visceral organs. On the basis of this information, the role of known mast cell 
mediators modulating smooth muscle cells’ activity in studied organs and tissues is dis-
cussed.  
2. Brief characteristics of the mast cell and its role for smooth muscle 
The mast cell (Mastocytus) or tissue basophilic granulocyte (Granulocytus basophilus textus) 
was observed for the first time about 150 years ago and since then, is described as a 
connеctive tissue cell. Mastocytes are usually present in loose connective tissue of organs, 
communicating with the environment – digestive and respiratory organs, skin.  
It is acknowledged that the structure and the function of mast cells are similar to those of 
blood basophils, but the two cell types have different precursors [5]. The main biological 
function of mast cells is the release of inflammatory mediators and cytokines [6]. They are 
outlined as cells with paracrine secretion (messenger-producing cells), whose products 
disseminate in the extracellular fluid and act on adjacent target cells [7]. Furthermore, mast 
cells are rich in histamine, heparin and proteases. Histamine is a vasoconstrictor increasing 
the permeability of small venules and stimulator of small-airway smooth muscle 
contraction. Heparin acts as an anticoagulant and is thought to stimulate angiogenesis [8]. 
Heparin proteoglycan, released by activated mast cells, inhibits the proliferation of smooth 
muscle cells in arterial tunica media and uterine myometrium [9, 10].  
The accumulated evidence on biologically active substances, synthesized, stored and 
released by mast cells over the last 2-3 decades not only added to the information about 
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their heterogeneity and biology, but also gives reason to re-evaluate their participation in 
important processes as the homeostasis, immune response, allergy, neurotransmission, 
vasomotor activity and motility of smooth muscle tissue. With regard to the blood flow 
to organs and blood circulation, the research on vasoactive substance released by mast 
cells and playing a key role in the vascular motorics, is particularly important. This role 
is primarily related to blood flow regulation in various functional states – both 
physiological and pathological. The tentative role of mast cells in the modulation of 
splanchnic wall smooth muscle tissue, accomplished by specific mediators, is 
comparable.  
Despite the abundant literature data related to the morphology, localization, histochemical 
behaviour, species-related features and involvement in systemic homeostasis, immune 
response, allergy, anaphylaxis etc. of tissue basophil granulocytes (mastocytes), the 
information about their presence in smooth muscle tissue is still scarce.  
Among the nearly 70 biologically active substances found in mast cells so far, it could be 
affirmed that mast cell-derived ligands, which act as mediators of smooth muscle tissue 
motility, belongs to four groups, namely:  
Biogenic amines (incl. catecholamines): histamine, dopamine, serotonin 
Polypeptides (including neuropeptides): vasoactive intestinal polypeptide (VIP), 
endothelin 
Proteoglycans: heparin  
Free radicals: nitric oxide 
The content and expression of mentioned biologically active substances outline mastocytes 
as cells, involved in the functioning of the smooth muscles of internal organs and blood 
vessels.  
In our studies, histochemical and immunohistochemical methods were used on paraffin 
sections, cryostat, semi-thin and ultrathin sections.  
3. Considering selected substances 
3.1. Biogenic amines 
There are literature reports about mast cells containing biogenic amines, established by the 
method of [11] via alcian blue/safranin staining with relatively low рН of the staining 
solution (1.42). Such cells were identified in bovine trachea [12, 13], as well as in several 
porcine organs [14]. In porcine renal blood vessels, renal pelvis and ureter, the specific 
staining for biogenic amines and glycosaminoglycans allowed to determine the localization 
and counts of alcian-positive mast cells in the tunica media, on its boundary with the 
adventitia and less frequently on its boundary with the intima Fig. 1. It should be noted 
that alcian-positive mast cells in renal pelvis and ureter were preferentially located in the 
muscle layer compared to the other layers of the wall, with statistically significant 
differences [15, 16].  
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Figure 1. Longitudinal section from a part of the wall of the porcine kidney interlobar artery.  
int – intima; media – middle shell; advent - adventitia. The А+ mast cells (mc) are located mainly be-
tween the media and adventitia. Alcian blue – safranin. Bar = 50 μm. 
The observed findings were confirmed by electron microscopy as well Fig. 2. No direct con-
tact, neither specialized contact differentiations between mast cell and smooth muscle cell 
plasmalemmas, were noted in any case.  
 
Figure 2. Mast cell (Nmc), located between middle shell (media) and adventitia 
(adv) of porcine renal interlobar artery. TEM picture. Bar = 5μm. 
3.1.1. Histamine 
Histamine is a biogenic (vasoactive) amine, mediator of inflammation, gastric hydrochloric 
acid secretion and smooth muscle contraction [17]. Histamine is detected in mast cells, nerve 
and neuroendocrine cells, lungs, kidneys, cerebrovascular endothelial cells, peripheral nerv-
ous system [18]. It elicits a contractile response in smooth muscles and lowers blood pres-
sure [19].  
Histamine is released by mast cells in response to allergic reactions or tissue damage. The 
close vicinity of mast cells to blood vessels, together with the strong vascular effect of hista-
mine suggests that it could influence blood flow, including that of the brain [20]. Histamine 
acts upon visceral (smooth) musculature by contracting it [8].  
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Histamine has a marked cardiovascular effect as well. It provokes dilation of terminal arterioles 
and the other vessels from the microcirculatory vascular bed, increases the permeability of 
capillaries during oedema formation and causes contraction of smooth muscle cells of large 
arteries and veins. The relative predominance of these effects is species-dependent. For instance, 
the histamine-induced contraction of arterioles is strong in rodents, less pronounced in cats, 
while they are dilated in dogs, non-human primates, and humans [19]. It was initially thought 
that vascular effects of histamine were mediated only by Н1 receptors. Later data confirmed the 
presence of Н2 receptors. Histamine-induced changes in the permeability of small vessels were 
obviously mediated by Н1 receptors, whereas the role of Н2 receptors in small arteriole 
contractions is still uncertain. The exact ratio of Н1- and Н2- receptor involvements in vascular 
responses to histamine in the different animal species is variable [21]. 
In general, the effect of histamine on a specific regional vasculature could be best described 
as a result of its multiple effects on smooth muscle and the lining endothelium. Н1 and Н2 
receptors on vascular smooth muscle mediate direct constriction and relaxation, respective-
ly, while endothelial Н1 receptors promote vasorelaxation via release of endothelial-derived 
relaxing factor (EDRF: i.е. nitric oxide) and/or prostacyclin. It is supposed that the trans-
membrane signalling mechanisms are involved in the different effects of histamine on vas-
cular smooth muscles [22, 23]. 
The role of histamine as a chemical mediator of renal autoregulation in some animal species 
is long acknowledged. Н1 receptors mediate the autoregulation of both renal blood flow and 
glomerular filtration rate in dogs, whereas in rabbits, both effects are present – Н1-mediated 
contraction and Н2-mediated relaxation of the renal artery [24-26].  
Immunohistochemically, histamine-positive mast cells were found in all layers of renal 
blood vessels in pigs [16]. They were most numerous in the tunica media, as well as at the 
boundary between media and adventitia (Fig. 3). In the tunica media of arcuate arteries, 
histamine-positive mastocytes were relatively few, while in arcuate veins were observed 
only as single findings.  
 
Figure 3. Histamine positive mast cell (mc) between media and adventitia of porcine interlobar artery. 
Bar = 30 μm 
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Histamine-positive mast cells were also detected in the middle layer of the renal pelvis and 
the ureter of the pig [15, 16], (Fig. 4).  
 
Figure 4. Two histamine positive mast cells (mc) in the circular smoothlayer (sm) of porcine ureter. tm 
– mucosal sheet. Bar = 25 μm 
3.1.2. Dopamine 
Dopamine belongs to the group of catecholamines, which are direct-acting sympatho-
mimetic amines. Adrenergic nerves are not required for their effects because they acti-
vate the receptors of effector cells. This is mainly valid for already synthesized and exog-
enous catecholamines [27]. Before, dopamine was believed to be important only as an 
immediate precursor of norepinephrine (noradrenalin, levarterenol, arterenol), but later 
some of its important physiological functions in mammals were revealed and thus, it was 
considered more thoroughly in some clinical states in men [28]. Apart from its signifi-
cance for nervous system, dopamine is tightly related in cardiovascular activity. Cardio-
vascular effects of dopamine depend on the activation of different types of catechola-
mine receptors. Its pressor effect is inhibited by an α blocker (such as phenoxyben-
zamine). Cardiac stimulating effects however, could be inhibited by a β blocker (for ex-
ample, propranolol) [29].  
Dopaminergic receptors of vascular beds could be considered a fifth adrenergic receptor 
subtype. Although the physiological significance of dopamine receptors is unknown, this 
type is important for clinical pharmacology as it is involved in vasodilator responses in 
renal, coronary and brain circulatory beds. The activation of these receptors by dopa-
mine is highly selective, while the agonistic activity of other catecholamines is minor 
[27]. 
By opinion of [29] dopamine induced a reduction of vascular resistance and increases the 
blood flow to kidneys and mesenteries blood vessels, together with myocardial stimulation. 
This partial effect of dopamine could be advantageous in the treatment of shock compared 
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to conventional catecholamines, because norepinephrine and epinephrine induce a marked 
contraction of renal and mesenterial arteries secondary to α-receptor effects. 
The selective vasodilation of renal and visceral beds by dopamine suggested its use in 
clinical cardiac dysfunctions. It is successfully used in treatment of shock as it dilates renal 
arteries through activation of dopamine-1 (DA1) receptors and enhances cardiac activity via 
activation of cardiac -adrenergic receptors [20, 27]. Dopamine receptors on vascular 
smooth muscles are classified by [30, 31] as DA1.  
With regard to the presence of dopamine in mast cells, data available so far describe it as 
mastocyte amine mediator only in ruminants [32]. 
Using a histochemical reaction for the detection of tyrosine hydroxylase (TH) – a primary 
enzyme in dopamine synthesis pathway in porcine kidney, it was found out that TH-
positive mast cells were predominantly localized at two sites: the renal sinus and in 
glomeruli of the superficial, middle and juxtamedullary cortical zones [16]. TH-positive 
mast cells in the renal sinus were usually seen as single cells, less frequently as clusters of 
several cells near the large blood vessels (Fig. 5). 
 
Figure 5. A. TH-positive mast cells in the renal sinus, gathered near the blood vessels. Bar = 100 μm 
B. Some of TH-positive mast cells (upper half of 5A at a higher magnification). Bar = 40 μm 
TH-positive mast cells were not detected in the cortex. In our view, the absence of TH-
positive mast cells around and within cortical vessels is probably one of the reasons for the 
application of dopamine in spasms of the interlobular arteries to relieve anuria due to a 
variety of causes. Nevertheless, as outlined by [33], the application of dopamine in humans 
and some animal species with renal failure did not provoke the anticipated effect.  
3.2. Polypeptides 
3.2.1. Vasoactive intestinal polypeptide (VIP) 
The vasoactive intestinal polypeptide is a multifunctional peptide built of 29 amino acids, 
first isolated from porcine duodenum [34] and initially considered a potential vasodilator. 
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The extensive research on VIP in late 1980’s revealed that this peptide is a physiological 
regulator of essential body functions, namely brain metabolism and blood flow, 
gastrointestinal motility and secretion, neuroendocrine secretion, immune response, sexual 
activity and reproduction. Along its importance in carcinogenesis, VIP is also related to 
diseases such as bronchial asthma, urinary bladder fibrosis and AIDS [35].  
VIP was first described in mastocytes of rats and mice by [36], and its relationship to 
histamine was shown. Later, VIP was described in basophils as well [37]. As mast cells are 
abundant in the connective tissue of different organs, the contained VIP could influence the 
local or regional blood flow in both normal and pathological states [36]. 
It is acknowledged that VІР, some peptides and histamine secreted by mast cells are 
actively involved in the motility of smooth muscle (including vascular) cells and modulate 
the motility of smooth muscles in organs and the vascular wall through specific receptors 
[38–44].  
Mast cells, immunopositive to VIP were observed in large blood vessels, including arcuate 
arteries and veins of pigs [16]. Relatively high mast cells counts were established within the 
media of these vessels, with highest density in the renal artery. Less VIP-positive cells were 
observed on the boundary between the media and the adventitia. It should be emphasized 
that in arcuate arteries, VIP-positive mast cells were present only in the middle shell, with 
relatively regular distribution along the circumference of the blood vessel (Fig. 6). 
 
Figure 6. VIP positive mast cells (mc) in the middle shell (media) of porcine arcuate artery. Bar = 80 μm 
3.2.2. Endothelin 
Endothelin (ЕТ) is a brain-vascular peptide [45], with three isopeptides – ЕТ-1, ЕТ-2 and ЕТ-
3 [46]. Its various biological actions include, apart from the regulation of vasoconstriction 
and neurotransmission, the regulation of cytokine-regulated cell growth [47]. Out of the 
three ET isopeptides, ET-1 has marked effect mainly on smooth muscle cells of the vascular 
wall. 
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ЕТ-1 is a 21-amino acid peptide with a strong vasoconstrictor activity, first isolated from the 
supernatant of cultured endothelial cells. There is evidence that vascular smooth muscle 
cells are also capable to produce endothelin [48, 49]. Apart being a potent vasoconstrictor, 
ET-1 also exhibits hypertrophic, mitogenic and anti-apoptotic effects on vascular smooth 
muscle cells [50-52]. EТ-1 induces strong and prolonged contractile responses in vascular 
smooth muscle cells in different systems, with a special effect on the renal vascular bed [48, 
53-56]. Initially described as a vasoconstrictor, ET-1 is now acknowledged to participate in 
the pathogenesis of a number of disorders, i.e. vascular, inflammatory, fibrotic diseases via 
its multifunctional effects on mast cells, but under certain conditions [57]. 
ET-1 is widely spread in various tissues and organs, including the gastrointestinal tract. Its 
three isopeptides were detected mainly in mast cells and less frequently, in macrophages of 
Lamina propria of the stomach, small intestine and colon in Wistar rats. Apart the confirmed 
synthesis and secretion of ET by mast cells, its role as a new cytokine factor in these cells 
was suggested [46].  
ET was reported to be present in the basilar artery of the rat [58, 59] and post mortem, in 
human cerebrovascular nerves of the middle cerebral artery [60]. Immunoreactive ET-1 was 
also detected in endothelial cells of the intima, vascular smooth muscle cells and macro-
phages of the media and neointima, and in perivascular nerves (axons) varicosities at the 
boundary between media and adventitia of the middle cerebral artery in a patient with 
multiple system atrophy with autonomic deficiency [61]. ET-1 positivity of uterine smooth 
muscle cells and mast cells was reported in a post partum mouse, but its functions remained 
unclear [62]. More recent data [3] from in vitrо investigations showed the contractile effect of 
ET-1 on longitudinal smooth muscle of the equine cecum, mediated by ЕТА and ЕТВ recep-
tors. It was therefore concluded that the spontaneous contraction of equine caecal smooth 
musculature most probably originated in smooth muscle cells, and not in enteric nervous 
system. Having investigated the vasoconstrictor effect of ET-1 on resistant renal blood ves-
sels in a rabbit through in vitro microperfusion of afferent and efferent glomerular arterioles, 
[63] established a dose-dependent decrease in their lumen. 
Endothelin-immunopositive mast cells were present in the wall of both extrarenal and in-
trarenal blood vessels of the pig [16]. The largest amount of mast cells was observed in pe-
ripheral layers of tunica media, as well as on the boundary between media and adventitia. 
Endothelin-positive mastocytes were also observed in deeper layers of the media, in the 
connective tissue among smooth muscle cells. The detected mast cells were of different 
shape and with well visualized immunopositive granules. ET-positive mast cells in the wall 
of the renal vein were more rarely observed. Their localisation was similar to that in the 
renal artery. ET-positive mast cells were detected occasionally in the wall of intrarenal blood 
vessels, but only as single findings in arcuate and interlobular arteries and veins.  
The research of [64] on mast cells in the wall of canine sublobular hepatic veins by transmis-
sion electron microscopy has shown that ET-1 was present in both the cytoplasmic matrix 
and cytoplasmic granules. According to the author, the coexistence of ET-1 and histamine in 
mast cell granules was closely related to the strong vasoconstrictor effect on venous sphinc-
ters of canine liver.  
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3.3. Proteoglycans  
3.3.1. Heparin 
The strong correlation between the density of mast cells in tissues and the efficacy of tissue 
extracts to prevent blood coagulation, it was supposed long ago that mast cells contained 
the potent anticoagulant heparin. According to [65] heparin is the only large 
glycosaminoglycan and its amount in the cell is about 20 pg.  
Activated mast cells, releasing heparin proteoglycans, inhibit the proliferation of smooth 
muscle cells in the tunica media of human arterial wall, while histamine stimulates it [10]. It 
was demonstrated by [9] the inhibitory effect of heparin on human myometrium prolifera-
tion, suggesting that it could induce the differentiation of uterine smooth muscle cells and to 
influence tissue remodelling and reconstruction in different physiological and pathophysio-
logical events.  
Glycosaminoglycan-positive, including heparin-positive mast cells were observed by us [16] 
in the walls of extra and intrarenal blood vessels in pigs (Fig. 7). To determine the amount of 
heparin-containing mast cells, they were initially stained with 0.02 w/v aqueous berberine 
neutral sulfate solution and then, with 0.1% toluidine blue in McIlvane's buffer, рН 3 and 
observed by light microscopy. Calculating the ratio of berberine-positive (heparin) to 
toluidine positive (glycosaminoglycans) with well expressed γ-metachromasia mast cells, it 
was found out that 42% of mast cells in the renal vein media were berberine-positive, i.e. 
contained heparin in their granules. 
 
Figure 7. Mast cells (mc) in the media of porcine renal vein with well expressed γ-metachromasia.  
Bar = 30 μm 
Similar studies with mast cells localized in the internal anal sphincter part, adjacent to the 
paranal sinus wall in the dog, showed that 100% of the mast cells were berberine (heparin) 
positive [66]. Positive reaction was detected both in mast cells in the connective tissue 
stroma among smooth muscle cell clusters, as well as within packs, in close vicinity to 
smooth muscle cells (Fig. 8). These data, compared to previously cited repots allowed 
assuming that heparin-containing mast cells regulated the growth of smooth muscle cells 
not only in the vascular wall, but also in the external anal sphincter in dogs [16, 66].  
 




Figure 8. А. Heparin contained- berberin positive mast cells (arrows). IAS- internal anal sphincter.  
GA- apocrine glands. Male 4 years dog. Bar = 40 μm. (Courtesy by Dr I. Stefanov). 
B. Toluidine blue staining of the same area - 8A. Mast cells with γ-ma metachromasia – glycosamino-
glycans (arrows). Bar = 40 μm. (Courtesy by Dr I. Stefanov). 
3.4. Radicals 
3.4.1. Nitric oxide 
Nitric oxide (NO) is a molecular free-radical gas, an important mediator with a variety of 
functions [67]. NО is biosynthesized from the guanidine nitrogen (NG) of L-arginine through 
conversion of the intermediate compound Nω-hydroxy L-arginine by nitric oxide synthase 
(NOS) enzyme family. As this family of enzymes incorporates molecular oxygen, NOS are 
classified as dioxygenases with similar features with cytochrome P-450 reductase. Cofactors 
needed for NO synthesis include flavin adenine dinucleotide (FAD), flavin mononucleotide, 
nicotinamide adenine dinucleotide phosphate (NADPH), haemoglobin and 
tetrahydrobiopterin.  
Three NOS isoforms are known– NOS 1 (neuronal, nNOS), NOS 2 (inducible, iNOS) and 
NOS 3 (endothelial, еNOS). NOS 1 and NOS 3 (nNOS and еNOS) are also described as con-
stitutive NOS (cNOS), the other original form is iNOS. NOS-coding genes are localised in 
different chromosomes. The structure of enzymes is common, i.e. oxygenase, reductase 
domain and calmodulin-binding site, with 51 to 57% homology in amino acid sequences. 
The C-terminal reductase domain possesses binding sites for FMN-, FAD- and NADPH, and 
is linked to the oxygenase domain by a calmodulin-binding site [68, 69]. 
Apart regulating the mast cell phenotype and function [70], NO is also produced by mast 
cells. There are numerous data confirming the production of this important signalling mole-
cule by mast cells [71], but also data opposing to this statement [72]. 
There is increasing evidence in support of the fact that the release of mediators by mast cells 
is regulated by NO, most probably through posttranslational modification of proteins. The 
three isoforms of NOS are expressed in mast cells, although other cells also produce NO that 
A B
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could regulate mast cells' function. Probably, each of NOS isoforms in mast cells coordinates 
a specific outcome depending on the mast cell phenotype, subcellular distribution of the 
enzyme and the presence of various cofactors [72]. 
By [68] it was demonstrated that NO generated via eNOS is the main vasodilator responsi-
ble for hypotension in anaphylactic shock. The authors believe that soluble guanylate 
cyclase is the main vasorelaxing mediator of NO. These data support the surprising hypoth-
esis that not iNOS but eNOS was the principal factor of vascular dilation in a state of ana-
phylaxis. Thus, eNOS and/or PI3K and Akt are defined as novel possible targets in anaphy-
laxis treatment. 
Our studies on renal blood vessels in pigs showed that there were no mast cells, positive for 
NADPH-d and NOS [16]. Mastocytes positive to these ligands were detected in the internal 
anal sphincter of the dog [66]. In sexually mature animals, NADPH-d-positive mast cells 
were statistically significantly more numerous per 0.1 mm2 than NOS-positive cells – 
3.27±0.78, vs. 1.65±0.62 (р< 0.001). 
 
Figure 9. NADPH-d positive mast cells (arrows) and nerves (n) in dog’s internal anal sphincter (MSAI).  
Bar = 15μm. (Courtesy by Dr I. Stefanov) 
4. Some morphofunctional aspects of the interaction between smooth 
muscle cells and mast cells 
The presence of mast cells containing biogenic amines and other mediators, the histochemi-
cal evidence for aforementioned ligands and more recent literature data suggesting that the 
nervous system is perhaps not the only mediator of smooth muscle contractility [3], allowed 
to hypothesize that mast cells were actively involved in smooth muscle cells motility. In 
support of this assumption, a detailed study of mast cells in the ureteral wall was conducted 
[15]. The results convincingly demonstrated that their role was substantial and incontesta-
ble. The highest mast cell density per mm2 in the muscular layer of the ureter (16.7±3.3) 
compared to mucosa and adventitia (7.3±1.8 and 11.1±2.7, respectively) was probably related 
to the marked activity of closely situated smooth muscle cells. This assumption is based 
upon the opinion of [13] about bovine tracheal mast cells. Ureteral smooth musculature 
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activity is manifested, in the first place, by periodic contractions sending urine into the uri-
nary bladder (due to the horizontal position of the animal) and second, by blood flow regu-
lation through vasoconstriction control [73] and/or modulation of smooth muscle activity 
[38, 41, 43]. This primary activity of mast cells in the porcine ureter is different to that in 
other organs such as lungs, alimentary organs and the skin, where mast cells are involved in 
immune response to external antigens, easily invading the body in large amounts [6]. This 
could be attributed to the specific retroperitoneal localisation of the ureter [74], which is 
relatively unexposed to such antigens. 
It is well acknowledged that autonomic nerve fibres did not connect each smooth muscle 
cell in a large part of organs and blood vessels [2, 75]. Therefore, signals could be 
transmitted by nexus ion channel contact between mast cells and muscle cells – most 
probably via substances like Ca2+, Mn2+ [76], K+ [77], Cl– [78, 79], enzymes [73], biologically 
active substances as the vasoactive intestinal polypeptide – VIP [36, 37], histamine [13, 73, 
80], and substance P [81], all of them responsible for signal transduction.  
The detailed elucidation of mast cells effects on smooth muscle cells requires special 
attention on the tentative role of mastocytes in myometrium recovery [82], emergence of 
smooth muscle contraction [3], and the specificity of autonomic innervation of smooth 
muscle tissue [1, 75].  
5. Conlusion 
The presented data convincingly show that mast cells are normally resident cells in the 
smooth muscle layer of the blood vessels and the visceral organs. Established biologic active 
substances in observed mast cells with emphasized importance for smooth muscle motility 
give a reason to believe that mast cells via these substances take part in modulation of 
smooth muscle cells activity. This presumption could be useful for further investigations, 
which apparently will allow more detailed elucidation on mast cells function in smooth 
muscle tissue, as whole. 
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